Executive Summary

Transaction Overview

Borrower: The Procter & Gamble Company (NYSE: PG)
Facility: Information not available in the provided memo.
Use of Proceeds: Information not available in the provided memo.
Fiscal Year End: June 30; analysis covers FY2023–FY2025
Credit Profile: Investment-grade; large-cap consumer staples issuer with publicly traded debt and equity

Business Overview

Scale & market position: P&G is one of the world's largest FMCG companies, generating $84.3B in net sales (FY2025) across five segments — Fabric & Home Care, Baby/Feminine/Family Care, Beauty, Grooming, and Health Care — sold in approximately 180 countries.
Business model: Mature, make-to-stock branded-goods platform competing on brand equity, scale-driven cost efficiency, and sustained R&D investment (~$1.9–$2.1B annually); no ramp-stage risk.
End-market characteristics: Non-discretionary, daily-use consumption provides structural demand stability across economic cycles; North America represents ~45–47% of net sales, with meaningful diversification across Europe and Asia-Pacific.
Customer concentration: Walmart (incl. Sam's Club) represents ~15% of consolidated net sales — the sole disclosed customer exceeding 10%; relationship is long-standing and multi-category.

Credit Strengths

Exceptional cash generation: Three-year average FCF of ~$14.8B; FCF/Total Debt of 0.41x (FY2025) implies theoretical full debt retirement in ~2.5 years.
- CFO of $17.8B (FY2025) comfortably covers CapEx ($3.8B), interest ($907M), and CPLTD ($9.5B).
Conservative leverage with improving trajectory: Net Debt/EBITDA declined from 1.97x (FY2024) to 1.82x (FY2025); Debt/Capital of ~39.8% with $52.3B equity base.
Structural negative working capital: CCC of approximately -56 days (FY2025) and DPO of ~113 days reflect dominant supplier leverage; WCR of -$12.8B is a net liquidity source.
Very strong interest coverage: EBITDA/IE of 20.9x and EBIT/IE of 22.5x (FY2025); interest expense of $907M is de minimis relative to $18.9B EBITDA.
Sustained margin expansion: Gross margin improved ~330bps to 51.2% (FY2025); EBITDA margin inflected to 22.4% from 19.6% in FY2024, with operating margin reaching 24.3%.

Key Risks

Shareholder return priority consumes substantially all FCF: Financing outflows of ~$14.0B (FY2025) — dividends plus buybacks — leave limited residual cash for accelerated deleveraging; structural feature at current leverage levels but constrains balance sheet flexibility.
CPLTD step-up creates near-term refinancing exposure: Current portion of long-term debt increased from $7.2B (FY2024) to $9.5B (FY2025); cash coverage is near 1:1 ($9.6B cash), with execution dependent on continued capital markets access.
Single-customer concentration: Walmart represents ~15% of net sales; any deterioration in the commercial relationship or channel shift would have a material top-line impact.
FX and geopolitical exposure: Meaningful revenue base in emerging markets and Europe introduces currency translation risk and geopolitical sensitivity (Russia/Ukraine, Middle East).
Grooming segment structural headwinds: Gillette/Venus face secular volume pressure from declining shaving frequency; premiumization provides partial offset but does not fully neutralize unit volume erosion.
Undrawn revolver not confirmed: Committed credit facility availability is not included in the provided dataset; total liquidity assessment may be understated pending verification.

Financial Performance

Revenue: $82.0B (FY2023) → $84.0B (FY2024) → $84.3B (FY2025); growth decelerating to +0.3% in FY2025, consistent with mature large-cap staples profile.
EBITDA: $16.4B (FY2023) → $16.5B (FY2024) → $18.9B (FY2025); FY2025 step-up of +$2.4B reflects operating leverage and cost discipline; margin of 22.4%.
Net income: $14.5B (FY2023) → $16.3B (FY2025); net margin expanded from 17.7% to 19.4%.
Leverage: Total Debt/EBITDA of 1.82x (FY2025); Net Debt/EBITDA improving YoY; total debt of $34.5B against $52.3B equity.

Liquidity & Coverage

Cash: $9.6B as of FY2025; near 1:1 coverage of $9.5B CPLTD on a spot basis.
FFO: $13.5B (FY2025); FFO/Total Debt of 0.39x; provides ample annual debt service capacity.
Interest coverage: EBITDA/IE of 20.9x; EBITDA/(IE + CPLTD) of 2.20x — tightened from 2.63x in FY2024 due to CPLTD increase, but remains comfortable.
Current ratio: 0.70x (FY2025) — sub-1.0x is sector-normal given structural negative working capital; not a liquidity concern.
Revolver: Undrawn committed credit facility availability not confirmed in provided data; verification recommended.

Recommendation

Procter & Gamble presents a compelling investment-grade credit profile underpinned by exceptional cash generation (~$14.8B average FCF), conservative leverage (1.82x Net Debt/EBITDA), very strong interest coverage (20.9x EBITDA/IE), and a structurally negative working capital model that functions as a permanent liquidity source. The primary credit considerations — near-term CPLTD of $9.5B, Walmart concentration at ~15% of sales, and ~$14.0B in annual shareholder return outflows — are well-managed at current earnings levels and consistent with P&G's long-established capital allocation framework. The FY2025 EBITDA inflection to $18.9B and margin expansion to 22.4% provide incremental credit support. The Committee is recommended to approve the facility, subject to confirmation of undrawn revolving credit facility availability and review of the debt maturity schedule.

Pros

Scale and brand durability: $84.3B revenue base across 180 countries; portfolio of category-leading brands with non-discretionary demand characteristics.
FCF consistency: Three-year average FCF of ~$14.8B; CapEx/CFO of ~21% leaves substantial residual cash flow.
Improving leverage: Net Debt/EBITDA of 1.82x (FY2025), down from 1.97x; EBITDA growth outpacing incremental debt issuance.
Structural working capital advantage: DPO of ~113 days and CCC of -56 days; WCR of -$12.8B is a net source of liquidity.
Margin expansion confirmed: Gross margin +330bps over three years; EBITDA margin step-up to 22.4% in FY2025 demonstrates operating leverage.
Experienced management team: CEO, CFO, and COO each have 20+ years of P&G tenure; leadership continuity is a credit-positive.

Cons

Shareholder returns consume substantially all FCF: ~$14.0B financing outflows in FY2025 limit organic deleveraging capacity; balance sheet flexibility is structurally constrained.
CPLTD concentration: $9.5B current maturities in FY2025 require timely capital markets execution; cash coverage is near 1:1 with no confirmed revolver backstop in the provided data.
Walmart dependency: Single customer at ~15% of net sales; loss or material reduction of this relationship would be a significant credit event.
Revenue growth near-stagnant: +0.3% top-line growth in FY2025 limits organic earnings upside; margin expansion is the primary earnings driver, which may not be indefinitely sustainable.
FX and geopolitical risk: Meaningful EM and European revenue exposure introduces earnings volatility from currency translation and macro disruption.
Grooming secular decline: Structural volume headwinds in the Gillette/Venus franchise represent a slow-moving but persistent drag on segment contribution.